| Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis SJ Mandriota, L Jussila, M Jeltsch, A Compagni, D Baetens, R Prevo, ... The EMBO journal, 2001 | 1395 | 2001 |
| Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly SS Foo, CJ Turner, S Adams, A Compagni, D Aubyn, N Kogata, ... Cell 124 (1), 161-173, 2006 | 532 | 2006 |
| Mammalian sprouty-1 and-2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells MA Impagnatiello, S Weitzer, G Gannon, A Compagni, M Cotten, ... The Journal of cell biology 152 (5), 1087-1098, 2001 | 316 | 2001 |
| Fibroblast growth factors are required for efficient tumor angiogenesis A Compagni, P Wilgenbus, MA Impagnatiello, M Cotten, G Christofori Cancer research 60 (24), 7163-7169, 2000 | 294 | 2000 |
| Control of skeletal patterning by ephrinB1-EphB interactions A Compagni, M Logan, R Klein, RH Adams Developmental cell 5 (2), 217-230, 2003 | 272 | 2003 |
| How early implementations influence later adoptions of innovation: Social positioning and skill reproduction in the diffusion of robotic surgery A Compagni, V Mele, D Ravasi Academy of Management Journal 58 (1), 242-278, 2015 | 196 | 2015 |
| Recent advances in research on multistage tumorigenesis A Compagni, G Christofori British journal of cancer 83 (1), 1-5, 2000 | 171 | 2000 |
| Sustaining universal health coverage: the interaction of social, political, and economic sustainability E Borgonovi, A Compagni Value in health 16 (1), S34-S38, 2013 | 128 | 2013 |
| Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells G Bunone, A Mariotti, A Compagni, E Morandi, G Della Valle Oncogene 14 (12), 1463-1470, 1997 | 116 | 1997 |
| Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic β cells controlled by the tet-on regulatory system D Landesman-Milo, M Surana, I Berkovich, A Compagni, G Christofori, ... Cell transplantation 10 (7), 645-650, 2001 | 101 | 2001 |
| Response to COVID-19: was Italy (un) prepared? I Bosa, A Castelli, M Castelli, O Ciani, A Compagni, MM Galizzi, ... Health Economics, Policy and Law 17 (1), 1-13, 2022 | 91 | 2022 |
| Orphan drug legislation: lessons for neglected tropical diseases S Villa, A Compagni, MR Reich The International journal of health planning and management 24 (1), 27-42, 2009 | 84 | 2009 |
| Maintaining strategic ambiguity for protection: Struggles over opacity, equivocality, and absurdity around the Sicilian Mafia G Cappellaro, A Compagni, E Vaara Academy of Management Journal 64 (1), 1-37, 2021 | 60 | 2021 |
| International pathways to mental health transformation N Adams, A Daniels, A Compagni International Journal of Mental Health 38 (1), 30-45, 2009 | 58 | 2009 |
| Corona-regionalism? Differences in regional responses to COVID-19 in Italy I Bosa, A Castelli, M Castelli, O Ciani, A Compagni, MM Galizzi, ... Health Policy 125 (9), 1179-1187, 2021 | 48 | 2021 |
| The policy of public health genomics in Italy B Simone, W Mazzucco, MR Gualano, A Agodi, D Coviello, FD Bricarelli, ... Health policy 110 (2-3), 214-219, 2013 | 44 | 2013 |
| Avoiding adverse drug reactions by pharmacogenetic testing: a systematic review of the economic evidence in the case of TPMT and AZA-induced side effects A Compagni, S Bartoli, B Buehrlen, G Fattore, D Ibarreta, EG de Mesa International journal of technology assessment in health care 24 (3), 294-302, 2008 | 42 | 2008 |
| General practitioners’ adherence to evidence-based guidelines: a multilevel analysis MP Fantini, A Compagni, P Rucci, S Mimmi, F Longo Health care management review 37 (1), 67-76, 2012 | 40 | 2012 |
| International pathways to mental health system transformation: Strategies and challenges A Compagni, N Adams, A Daniels California Institute for Mental Health, 2007 | 40 | 2007 |
| Governing through evidence: a study of technological innovation in health care V Mele, A Compagni, M Cavazza Journal of Public Administration Research and Theory 24 (4), 843-877, 2014 | 26 | 2014 |
